Literature DB >> 23206204

Predictors of serosorting and intention to serosort among men who have sex with men, San Francisco.

Yea-Hung Chen1, Snigdha Vallabhaneni, H Fisher Raymond, Willi McFarland.   

Abstract

The objectives of this study were to characterize men who have sex with men (MSM) with intention to serosort and to identify factors associated with subsequent failure, defined as potentially discordant unprotected anal intercourse (PDUAI) events. Time-location sampling was used to recruit MSM into a longitudinal study of seroadaptive behaviors in San Francisco. Intention to serosort was assessed at baseline, while sexual behavior in the subsequent 6 months was assessed at follow-up. HIV-negative frequent methamphetamine users were less likely (odds ratio [OR] = 0.14; 95% CI [0.03, 0.81]) and HIV-positive frequent methamphetamine users were more likely (OR = 1.99; 95% CI [1.07, 3.69]) to intend to serosort than nonusers. Among HIV-positive and HIV-negative MSM with intent to serosort, those who frequently used alcohol, methamphetamine, or "downers" had significantly more episodes of PDUAI compared to nonusers. Challenges to serosorting, particularly substance use, should be addressed in HIV prevention and treatment programs that promote seroadaptive behaviors.

Entities:  

Mesh:

Year:  2012        PMID: 23206204     DOI: 10.1521/aeap.2012.24.6.564

Source DB:  PubMed          Journal:  AIDS Educ Prev        ISSN: 0899-9546


  9 in total

1.  Substance-use and sexual harm reduction strategies of methamphetamine-using men who have sex with men and inject drugs.

Authors:  J Michael Wilkerson; Syed W Noor; Ellen D Breckenridge; Adeniyi A Adeboye; B R Simon Rosser
Journal:  AIDS Care       Date:  2015-04-02

2.  Prevalence of and Factors Associated with the Use of HIV Serosorting and Other Biomedical Prevention Strategies Among Men Who Have Sex with Men in a US Nationwide Survey.

Authors:  Christian Grov; H Jonathan Rendina; Viraj V Patel; Elizabeth Kelvin; Kathryn Anastos; Jeffrey T Parsons
Journal:  AIDS Behav       Date:  2018-08

3.  Using expert opinion to quantify unmeasured confounding bias parameters.

Authors:  Soodabeh Navadeh; Ali Mirzazadeh; Willi McFarland; Sarah Woolf-King; Mohammad Ali Mansournia
Journal:  Can J Public Health       Date:  2016-06-27

Review 4.  Seroadaptation among men who have sex with men: emerging research themes.

Authors:  Susan Cassels; David A Katz
Journal:  Curr HIV/AIDS Rep       Date:  2013-12       Impact factor: 5.071

5.  Correlates of Seroadaptation Strategies Among Black Men Who have Sex with Men (MSM) in 4 US Cities.

Authors:  Leo Wilton; Beryl Koblin; Vijay Nandi; Guozhen Xu; Carl Latkin; David Seal; Stephen A Flores; Pilgrim Spikes
Journal:  AIDS Behav       Date:  2015-12

6.  Prospective predictors of unprotected anal intercourse among HIV-seropositive men who have sex with men initiating antiretroviral therapy.

Authors:  David W Pantalone; David Huh; Kimberly M Nelson; Cynthia R Pearson; Jane M Simoni
Journal:  AIDS Behav       Date:  2014-01

7.  The role of intent in serosorting behaviors among men who have sex with men sexual partnerships.

Authors:  Aaron J Siegler; Patrick S Sullivan; Christine M Khosropour; Eli S Rosenberg
Journal:  J Acquir Immune Defic Syndr       Date:  2013-11-01       Impact factor: 3.731

8.  Latent Class Analysis of Polysubstance Use and Sexual Risk Behaviors among Men Who Have Sex with Men Attending Sexual Health Clinics in Mexico City.

Authors:  Rosibel Rodríguez-Bolaños; Ricardo Baruch-Dominguez; Edna Arillo-Santillán; Elsa Yunes-Díaz; Leonor Rivera-Rivera; Lizeth Cruz-Jiménez; James F Thrasher; Alan G Nyitray; Eduardo Lazcano-Ponce
Journal:  Int J Environ Res Public Health       Date:  2022-07-21       Impact factor: 4.614

9.  Sexual mixing and the risk environment of sexually active transgender women: data from a respondent-driven sampling study of HIV risk among transwomen in San Francisco, 2010.

Authors:  Erin C Wilson; Glen-Milo Santos; H Fisher Raymond
Journal:  BMC Infect Dis       Date:  2014-08-06       Impact factor: 3.090

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.